| Literature DB >> 24728297 |
Eleni Plessa1, Giannoula S Tansarli2, Dimitrios Xanthopoulos3, Matthew E Falagas4.
Abstract
BACKGROUND: Although there is satisfactory recording of diseases affecting travelers visiting developing countries, little is known regarding morbidity of travelers when visiting developed countries. We sought to evaluate the morbidity of foreign travelers in Zakynthos, a popular Greek island attracting large number of foreign tourists every summer.Entities:
Mesh:
Year: 2014 PMID: 24728297 PMCID: PMC3984145 DOI: 10.1371/journal.pone.0094416
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic characteristics of 2,688 patients.
| Characteristic |
|
| Age (y), mean ± SD | 29.6±18.3 |
| Age group (y) | |
| 0–5 | 221 (8.2) |
| 6–11 | 186 (6.9) |
| 12–17 | 150 (5.6) |
| 18–40 | 1,385 (51.5) |
| 40–60 | 436 (16.2) |
| >60 | 217 (8.1) |
| NR | 92 (3.4) |
| Gender (F) | 1,533 (57) |
| Country | |
| United Kingdom | 740 (27.5) |
| Serbia | 586 (21.8) |
| Hungary | 471 (17.5) |
| Russia | 155 (5.8) |
| Poland | 138 (5.1) |
| Denmark | 110 (4) |
| Czech Republic | 97 (3.6) |
| Netherlands | 66 (2.5) |
| Romania | 59 (2.2) |
| Other | 266 (9.9) |
*Age was not recorded for 92 patients, while gender was not recorded for 7 patients.
** The remaining travelers were from Italy (36), former Yugoslav Republic of Macedonia (30), Finland (29), Sweden (27), Slovenia (26), Ireland (24), Bulgaria (17), Austria (16), Belgium (10), Germany (10), Norway (10), Croatia (11), Switzerland (5), Slovakia (2), Lithuania (2), Australia (1), France (1), Ukraine (2), Brazil (1), Bosnia (1), while relevant data was not recorded from 5 travelers.
Abbreviations
SD: standard deviation, y: year, F: female, UK: United Kingdom, SRB: Serbia, HU: Hungary, OR: odds ratio, CI: confidence interval
Morbidity of 2,688 patients by clinical category and most common specific diagnosis within each category.
|
|
|
|
|
|
| Otitis externa | 228 (8.5) |
| Tonsillitis | 103 (3.8) |
| Pharyngitis | 100 (3.7) |
| Common cold | 96 (3.6) |
| Otitis media | 88 (3.3) |
| Acute bronchitis | 54 (2) |
|
|
|
| Insect bite | 174 (6.5) |
| Sunburn | 101 (3.8) |
| Allergic rash | 97 (3.6) |
|
|
|
| Laceration | 81 (3) |
| Fractures | 77 (2.9) |
| Abrasion | 71 (2.6) |
| Sprains and dislocations | 53 (2) |
|
|
|
| Gastroenteritis | 385 (14.3) |
|
|
|
| Cystitis | 66 (2.5) |
|
|
|
| Conjunctivitis | 68 (2.5) |
|
|
|
| Lower extremity edema | 18 (0.7) |
| Alcohol intoxication | 8 (0.3) |
|
|
|
| Dyspepsia | 14 (0.5) |
|
|
|
| Hypertension | 10 (0.4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Abbreviations
SD: standard deviation, y: year, F: female, UK: United Kingdom, SRB: Serbia, HU: Hungary, OR: odds ratio, CI: confidence interval.
Morbidity and univariate analysis of 2,688 patients according to age, gender, month of travel, and duration of stay.
| Clinical category | Age (y) | p-value | Gender | p-value | Country | p-value | Month of visit | p-value | Duration of travel (d) | p-value | ||||||||||||
| <18 (557) | ≥18 (2038) | M (1148) | F (1533) | UK (740) | SRB (586) | HU (471) | Other (891) | May (133) | June (489) | July (874) | Aug (680) | Sept (425) | Oct (87) | <10 (1451) | 10–30 (1046) | >30 (54) | ||||||
| Respiratory tract | 267 47.9% | 582 28.6% | <0.001 | 422 36.8% | 453 29.5% | <0.001 | 213 28.8% | 224 38.2% | 103 21.9% | 339 38.1% | <0.001 | 39 29.3% | 133 27.2% | 297 34% | 268 39.4% | 122 28.7% | 20 23% | <0.001 | 400 27.6% | 417 39.9% | 18 33.3% | <0.001 |
| Dermatologic | 92 16.5% | 450 22.1% | 0.02 | 213 18.6% | 353 23% | 0.005 | 187 25.3% | 154 26.3% | 84 17.8% | 141 15.8% | <0.001 | 32 24.1% | 113 23.1% | 194 22.2% | 135 19.9% | 79 18.6% | 13 14.9% | 0.24 | 300 20.7% | 224 21.4% | 8 14.8% | 0.52 |
| Musculoskeletal injury | 55 9.9% | 373 18.3% | <0.001 | 220 19.2% | 218 14.2% | 0.001 | 141 19.1% | 74 12.6% | 61 13% | 164 18.4% | 0.001 | 31 23.3% | 75 15.3% | 132 15.1% | 97 14.3% | 83 19.5% | 22 25.3% | 0.006 | 255 17.6% | 150 14.3% | 12 22.2% | 0.002 |
| Gastrointestinal | 97 17.4% | 332 16.3% | 0.62 | 157 13.7% | 281 18.3% | 0.001 | 74 10% | 70 11.9% | 170 36.1% | 125 14% | <0.001 | 12 9% | 91 18.6% | 145 16.6% | 96 14.1% | 78 18.4% | 17 19.5% | 0.04 | 306 21.1% | 114 10.9% | 5 9.3% | <0.001 |
* Data on age, gender, and duration of travel was not available for 92, 7, and 137 patients, respectively.
Abbreviations
y: year, F: female, M: male, d: day, UK: United Kingdom, SRB: Serbia, HU: Hungary, OR: odds ratio, CI: confidence interval, Aug: August, Sept: September, October.
Multivariate analysis regarding the development of the 4 most common categories of disease in 2,688 patients.
| Variable | Respiratory tract | Dermatologic | Musculoskeletal injury | Gastrointestinal | ||||||||
| OR | 95% CI | p-value | OR | 95% CI | p-value | OR | 95% CI | p-value | OR | 95% CI | p-value | |
| Age (y) | ||||||||||||
| ≥18 | ||||||||||||
| <18 | 2.77 | 2.22–3.46 | <0.001 | 0.79 | 0.61–1.00 | 0.05 | 0.49 | 0.36–0.65 | <0.001 | 1.12 | 0.86–1.44 | 0.41 |
| Gender | ||||||||||||
| F | ||||||||||||
| M | 0.75 | 0.62–0.9 | 0.002 | 1.25 | 1.03–1.53 | 0.03 | 0.64 | 0.51–0.79 | <0.001 | 1.39 | 1.11–1.73 | 0.004 |
| Country | ||||||||||||
| UK | 1.37 | 1.05–1.79 | 0.02 | 0.9 | 0.7–1.14 | 0.38 | 1.29 | 1.01–1.64 | 0.04 | 0.62 | 0.48–0.8 | <0.001 |
| SRB | 6.7 | 5.16–8.71 | <0.001 | 1.24 | 0.97–1.59 | 0.09 | 0.13 | 0.08–0.21 | <0.001 | 0.44 | 0.33–0.6 | <0.001 |
| HU | 8.22 | 6.23–10.85 | <0.001 | 0.28 | 0.19–0.41 | <0.001 | 0.33 | 0.22–0.48 | <0.001 | 0.4 | 0.29–0.57 | <0.001 |
| Other | … | … | <0.001 | … | … | <0.001 | … | … | <0.001 | … | … | <0.001 |
| Month of visit | ||||||||||||
| May | 1.27 | 0.63–2.56 | 0.51 | 2.06 | 0.98–4.31 | 0.06 | 1.01 | 0.51–2.00 | 0.99 | 0.39 | 0.17–0.89 | 0.03 |
| June | 0.99 | 0.54–1.82 | 0.98 | 1.78 | 0.92–3.44 | 0.09 | 0.66 | 0.36–1.18 | 0.16 | 1.00 | 0.55–1.82 | 0.99 |
| July | 1.29 | 0.72–2.3 | 0.4 | 1.8 | 0.95–3.42 | 0.07 | 0.66 | 0.37–1.16 | 0.15 | 0.94 | 0.53–1.68 | 0.84 |
| Aug | 1.75 | 0.97–3.14 | 0.06 | 1.44 | 0.75–2.76 | 0.27 | 0.63 | 0.36–1.13 | 0.12 | 0.74 | 0.41–1.33 | 0.31 |
| Sept | 1.28 | 0.69–2.34 | 0.43 | 1.37 | 0.7–2.67 | 0.36 | 0.82 | 0.46–1.48 | 0.52 | 0.95 | 0.52–1.73 | 0.86 |
| Oct | … | … | 0.005 | … | … | 0.11 | … | … | 0.21 | … | … | 0.05 |
| Duration of travel (d) | ||||||||||||
| <10 | 0.52 | 0.27–0.99 | 0.04 | 1.63 | 0.75–3.54 | 0.21 | 0.98 | 0.49–1.96 | 0.96 | 2.66 | 1.03–6.82 | 0.04 |
| 10–30 | 0.88 | 0.46–1.67 | 0.7 | 1.76 | 0.81–3.8 | 0.15 | 0.73 | 0.37–1.46 | 0.37 | 1.52 | 0.59–3.91 | 0.39 |
| >30 | … | … | <0.001 | … | … | 0.31 | … | … | 0.03 | … | … | <0.001 |
* Data on age, gender, and duration of travel was not available for 92, 7, and 137 patients, respectively.
Abbreviations
y: year, F: female, d: day, UK: United Kingdom, SRB: Serbia, HU: Hungary, OR: odds ratio, CI: confidence interval, Aug: August, Sept: September, October.
Univariate and multivariate analyses regarding observation and need for hospitalization of 2,688 patients.
| Observation | Need for hospitalization | |||||||||||
| Univariate analyses | Multivariate analyses | Univariate analyses | Multivariate analyses | |||||||||
| Variable | Yes (n = 212) | No (n = 2,476) | p-value | OR | 95% CI | p-value | Yes (n = 78) | No (n = 2,610) | p-value | OR | 95%CI | p-value |
| Age (y) | ||||||||||||
| ≥18 | 178 (84) | 1,818 (73.4) | 51 (65.4) | 1,945 (74.5) | ||||||||
| <18 | 26 (12.3) | 572 (23.1) | <0.001 | 0.58 | 0.37–0.89 | 0.01 | 25 (32.1) | 573 (22) | 0.04 | 1.99 | 1.18–3.37 | 0.01 |
| Gender | ||||||||||||
| F | 117 (55.2) | 1,416 (57.2) | 40 (51.3) | 1,493 (57.2) | ||||||||
| M | 95 (44.8) | 1,053 (42.5) | 0.54 | 0.71 | 0.53–0.96 | 0.03 | 38 (48.7) | 1,110 (42.5) | 0.29 | 0.82 | 0.51–1.33 | 0.43 |
| Duration of travel (d) | ||||||||||||
| <10 | 103 (48.6) | 971 (39.2) | … | … | 0.04 | 30 (38.5) | 1,044 (40) | … | … | 0.77 | ||
| 10–30 | 92 (43.4) | 1,331 (53.8) | 0.73 | 0.54–0.99 | 0.04 | 43 (55.1) | 1,380 (52.9) | 1.09 | 0.67–1.78 | 0.72 | ||
| >30 | 8 (3.8) | 46 (1.9) | 0.003 | 1.58 | 0.69–3.6 | 0.28 | 1 (1.3) | 53 (2) | 0.85 | 0.55 | 0.07–4.18 | 0.56 |
| Category of disease | ||||||||||||
| Respiratory tract | 20 (9.4) | 859 (34.7) | … | … | <0.001 | 18 (23.1) | 861 (33) | … | … | <0.001 | ||
| Dermatologic | 43 (20.3) | 523 (21.1) | 3.25 | 1.88–5.64 | <0.001 | 0 (0) | 566 (21.7) | 0 | 0-. | 0.99 | ||
| Musculoskeletal injury | 26 (12.3) | 414 (16.7) | 2.36 | 1.30–4.30 | 0.005 | 13 (16.7) | 427 (16.4) | 1.79 | 0.85–3.78 | 0.13 | ||
| Gastrointestinal | 47 (22.2) | 392 (15.8) | 4.39 | 2.53–7.61 | <0.001 | 12 (15.4) | 427 (16.4) | 1.42 | 0.65–3.1 | 0.38 | ||
| Other | 76 (35.8) | 288 (11.6) | <0.001 | 10.14 | 6.03–17.05 | <0.001 | 35 (44.9) | 329 (12.6) | <0.001 | 6.25 | 3.36–11.64 | <0.001 |
* Data on age, gender, and duration of travel was not available for 92, 7, and 137 patients, respectively.
** The remaining clinical categories are reported in Tables 2 and 3.
Abbreviations
y: year, F: female, d: day, UK: United Kingdom, SRB: Serbia, HU: Hungary, OR: odds ratio, CI: confidence interval.